Cu-Mediated Synthesis of Indolines and Dihydroisoquinolinones Through Arylperfluoroalkylation of Unactivated Alkenes
Cu-Mediated Synthesis of Indolines and Dihydroisoquinolinones Through Arylperfluoroalkylation of Unactivated Alkenes
Cu-Mediated Synthesis of Indolines and Dihydroisoquinolinones Through Arylperfluoroalkylation of Unactivated Alkenes
Fluroalkylation
Cu-Mediated Synthesis of Indolines and Dihydroisoquinolinones
through Arylperfluoroalkylation of Unactivated Alkenes
Dandan Li,*[a] Yan Wang,[b] Zhenzhen Jia,[a] Zhaocheng Ou,[a] Yongrui Dong,[b] Cunjie Lv,[a]
Guangbin Fu,[a] and Deqiang Liang*[b]
Abstract: The copper-mediated fluroalkylation/cyclization of moderate to good yields with unactivated double bonds as the
N-allyl anilines has been described using fluoroalkyl iodides as radical acceptor. This protocol combines a simple experimental
fluoroalkylation reagents for the first time. The reaction pro- procedure with low-costing fluoroalkylated sources and excel-
vides an efficient and direct access to 3-fluoroalkyl indolines in lent functional group tolerance.
Eur. J. Org. Chem. 0000, 0–0 1 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
amount of 2a was further increased to 3.5 equiv., the yield of to the methyl group, we were unable to obtain any target prod-
3aa was not substantially improved (entry 18). Therefore, uct. Interestingly, the substrate N-benzyl-2-methylprop-2-en-1-
1 equiv. of 1a, 1.5 equiv. of Cu, and 3 equiv. of 2a at 120 °C in amine substituted with o-tolylsulfonyl group could also be tol-
DMSO (3 mL) for 6 h were chosen as the optimized conditions erated to give the six-membered product in a highly selective
for the Cu-mediated arylperfluoroalkylation reaction. manner (3xa). Moreover, if the methyl group R1 was replaced by
a hydrogen atom, we still obtained the corresponding indolines
Table 1. Optimization of the reaction conditions.[a] (3ya–3za). Furthermore, the reaction could be successfully ex-
tended to longer chain perfluoroiodo alkanes (C6F13I and
C8F17I), affording the corresponding products in good to excel-
lent yields (3ab–3ac). In addition, when BrCF2CO2Et was em-
ployed as a fluoroalkylating agent, 55 % yield of indoline deriva-
tive (3ad) obtained. We also attempted CF3I and CH3I as sub-
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 2 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
strates, however, either no or a trace amount of products were ylene under the standard conditions, we still could obtain the
detected. nC4F9-adduct product 6 in 45 % yield. These results indicated
Encouraged by the above-mentioned results, we next ex- that nC4F9 radical could be formed under these conditions.
plored the scope of allylamine protected by benzoyl groups Based on the above experimental results and literature re-
(Table 3). The substrate 4a bearing a methyl group on N atom ports,[8,10a,10b,12] a plausible mechanism for Cu-mediated aryl-
was tolerated under the standard conditions, affording the cor- perfluoroalkylation process was outlined in Scheme 2. First, RfX
responding six-ring product in 57 % yield (5aa). Moreover, two reacts with Cu to produce perfluoroalkyl radical Rf·, which un-
kinds of N-allylated benzylamines were also investigated. Unlike dergoes the addition with 1 to give the intermediate A. Then,
the o-tolylsulfonyl protected benzylamine (Table 2, 2w), the intermediate A is converted to intermediate B through the
benzoyl protected benzylamines selectively underwent ring clo- intramolecular radical cyclization. Finally, the generated Rf·
sure reaction with the phenyl ring of the benzoyl group, rather selectively abstracts a hydrogen atom from the intermediate B
than the phenyl ring of benzylamine group (5ba–5ca). to deliver the target product 3aa. It should be noted that a
mechanism involving Cu(I)-catalyzed perfluoroalkylation path-
Table 3. Synthesis of nC4F9-containing dihydroisoquinolinones by Cu-medi-
way[10c,13] could not be completely excluded.
ated aryltrifluoromethylation of unactivated alkenes.[a,b]
[a] Reaction conditions: 0.5 mmol of 4, 1.5 mmol of 2, and 1.5 equiv. of Cu
in 3 mL of DMSO at 120 °C for 6 h. [b] Isolated yield.
Experimental Section
General Information: Unless otherwise noted, all commercial ma-
terials and solvents were used without further purification. 1H NMR
and 13C NMR spectra were referenced to TMS and residue CHCl3 at
0.00 ppm and 77.16 ppm, respectively. High-resolution mass spec-
tra (HRMS) were measured with ESI in positive mode.
General Procedure for the Synthesis of N-Allyl Anilines or Sulf-
onamides Substrates (2b as an Example):[14] A mixture of p-tolu-
idine (1.607 g, 15.0 mmol), CH2Cl2 (50.0 mL), and Et3N (4.170 mL,
30.0 mmol), was placed in a round-bottom flask equipped with a
magnetic stir bar. To this mixture was added acetyl chloride
(1.273 mL, 18.0 mmol). The reaction mixture was stirred at room
temperature. After p-toluidine was consumed, as indicated by TLC,
the reaction mixture was quenched with aqueous NaHCO3 (100 mL)
and extracted with CH2Cl2 (100 mL) three times. The combined or-
ganic phase was washed with brine (50 mL) two times. After re-
moval of solvents, the solid of the crude product was further puri-
Scheme 1. Control experiments. fied by washing with a petroleum ether/ethyl acetate mixture (5:1,
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 3 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
v/v), affording N-(p-tolyl)acetamide as a white crystal. To a stirred 1.51 (d, J = 2.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 168.45,
solution of N-(ptolyl)acetamide (1.492 g, 10.0 mmol) and NaOH 138.98, 138.15, 133.97, 129.44, 122.62, 117.23, 61.64 (d, J = 6.3 Hz),
(600 mg, 15.0 mmol) in DMF (30.0 mL) was added 3-bromo-2-meth- 41.81, 39.41 (t, J = 20.4 Hz), 26.67 (d, J = 3.7 Hz), 24.25, 21.24; 19F
ylprop-1-ene (1.311 mL, 13.0 mmol), and the mixture was stirred at NMR (376 MHz, CDCl3) δ = –81.01 (t, J = 11.4 Hz, 3F), –107.82 to
ambient temperature. After N-(p-tolyl)acetamide was consumed, as –114.39 (m, 2F), –124.47 to –124.56 (m, 2F), –125.59 to –125.85 (m,
indicated by TLC, the reaction mixture was quenched with brine 2F); HRMS (ESI): m/z [M + H]+ calcd. for C17H17F9NO: 433.1161, found
(60 mL) and extracted with CH2Cl2 three times. The residue ob- 433.1163.
tained after evaporation of the solvent was purified by column
1-(5-Chloro-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-
chromatography on silica gel (petroleum ether/ethyl acetate = 20:1,
indolin-1-yl)ethanone (3ca): Yield 82 % (180.8 mg), white solid,
v/v) to afford N-(2-methylallyl)-N-(p-tolyl)acetamide 2a as a colorless
m.p. 89–90 °C. 1H NMR (400 MHz, CDCl3) δ = 8.16 (d, J = 8.6 Hz,
oil.
1H), 7.22 (dd, J = 8.6, 2.2 Hz, 1H), 7.10 (d, J = 2.2 Hz, 1H), 4.11 (d,
General Procedure for the Cu-Mediated Synthesis of Indolines J = 10.9 Hz, 1H), 3.91 (dd, J = 10.9, 1.6 Hz, 1H), 2.55–2.39 (m, 2H),
and Dihydroisoquinolinones: A mixture of N-allyl anilines 1a (1b– 2.24 (s, 3H), 1.53 (d, J = 2.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ =
z and 4a–c, 0.5 mmol), Cu (1.0 mmol, 63.5 mg) and RfX (1.5 mmol) 168.74, 139.97, 139.73, 129.09, 128.94, 122.52, 118.50, 61.57 (d, J =
in DMSO (3 mL) was stirred at 120 °C. The reaction was monitored 6.2 Hz), 41.86, 39.28 (t, J = 20.5 Hz), 26.77 (d, J = 3.7 Hz), 24.18; 19F
by TLC and stopped at the desired time. After the reaction was NMR (376 MHz, CDCl3) δ = –81.05 (t, J = 11.4 Hz, 3F), –108.02 to
finished, the mixture was filtered by a silica gel plug with ethyl –114.08 (m, 2F), –124.41 to –124.55 (m, 2F), –125.70 to –125.80 (m,
acetate (30 mL) as the eluent. The filtrate was washed with satu- 2F); HRMS (ESI): m/z [M + H]+ calcd. for C16H14ClF9NO: 442.0615,
rated brine (3 × 10 mL) and the organic phase was dried with found 442.0619.
Na2SO4, filtered, and concentrated under reduced pressure. The resi-
1-(3-Methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-5-phenyl-
due was separated on a silica gel column with petroleum ether/
indolin-1-yl)ethanone(3da): Yield 58 % (140.0 mg), white solid,
ethyl acetate as the eluent to get product 3aa (3ba–3za, 3ab–ac,
m.p. 151–152 °C. 1H NMR (400 MHz, CDCl3) δ = 8.28 (d, J = 8.4 Hz,
and 5aa–ca).
1H), 7.56 (dd, J = 8.3, 1.3 Hz, 2H), 7.51 (dd, J = 8.4, 1.9 Hz, 1H), 7.44
Experimental Details: N-(2-methylallyl)-N-phenylacetamide 1a (t, J = 7.6 Hz, 2H), 7.37–7.31 (m, 2H), 4.14 (d, J = 10.8 Hz, 1H), 3.94
(0.5 mmol), Cu (1.0 mmol, 63.5 mg), nC4H9I 2a (1.5 mmol, 258.2 μL), (dd, J = 10.8, 1.6 Hz, 1H), 2.63–2.46 (m, 2H), 2.27 (s, 3H), 1.58 (d, J =
and 1,1-diphenylethenein (1.0 mmol, 176.5 μL) in DMSO (3 mL) was 2.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 168.74, 140.73, 140.64,
stirred at 120 °C. The reaction was monitored by TLC and stopped 138.68, 137.57, 128.96, 127.92, 127.33, 127.02, 120.78, 117.63, 61.75
at the desired time. After the reaction was finished, the mixture was (d, J = 6.5 Hz), 41.90, 39.44, 26.82 (d, J = 3.7 Hz), 24.31; 19F NMR
filtered by a silica gel plug with ethyl acetate (30 mL) as the eluent. (376 MHz, CDCl3) δ = –81.02 (t, J = 11.4 Hz, 3F), –107.80 to –114.22
The filtrate was washed with saturated brine (3 × 10 mL) and the (m, 2F), –124.40 to –124.50 (m, 2F), –125.59 to –125.82 (m, 2F);
organic phase was dried with Na2SO4, filtered, and concentrated HRMS (ESI): m/z [M + H]+ calcd. for C22H19F9NO: 484.1317, found
under reduced pressure. The residue was separated on a silica gel 484.1319.
column with petroleum ether/ethyl acetate as the eluent to get
1-(3-Methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-2,3-dihydro-
product 6 (16 %, 31.9 mg).
1H-pyrrolo[3,2-c]pyridin-1-yl)ethanone (3ea): Yield 71 %
nC4H9I 2a (1.5 mmol, 258.2 μL), Cu (1.0 mmol, 63.5 mg), and 1,1- (144.8 mg), white solid, m.p. 103–104 °C. 1H NMR (400 MHz, CDCl3)
diphenylethenein (1.0 mmol, 176.5 μL) in DMSO (3 mL) was stirred δ = 8.51–8.36 (m, 2H), 8.04 (d, J = 5.6 Hz, 1H), 4.14 (d, J = 10.9 Hz,
at 120 °C. The reaction was monitored by TLC and stopped at the 1H), 3.93 (d, J = 10.9 Hz, 1H), 2.67–2.46 (m, 2H), 2.27 (s, 3H), 1.59 (s,
desired time. After the reaction was finished, the mixture was fil- 3H); 13C NMR (101 MHz, CDCl3) δ = 169.70, 150.86, 147.94, 144.22,
tered by a silica gel plug with ethyl acetate (30 mL) as the eluent. 133.26, 111.69, 65.38–60.33 (m), 41.11, 39.46 (t, J = 20.4 Hz) 27.37
The filtrate was washed with saturated brine (3 × 10 mL) and the (d, J = 3.1 Hz), 24.33; 19F NMR (376 MHz, CDCl3) δ = –81.05 (t, J =
organic phase was dried with Na2SO4, filtered, and concentrated 11.7 Hz, 3F), –108.16 to –113.86 (m, 2F), –124.41 to –124.51 (m, 2F),
under reduced pressure. The residue was separated on a silica gel –125.62 to –125.82 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for
column with petroleum ether/ethyl acetate as the eluent to get C15H14F9N2O: 409.0957, found 409.0958.
product 6 (45 %, 89.7 mg).
1-(3,5-Dimethyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)indolin-1-
1-(3-Methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)indolin-1-yl)- yl)propan-1-one (3fa): Yield 76 % (165.0 mg), white solid, m.p.
ethanone (3aa): Yield 74 % (150.5 mg), white solid, m.p. 103– 106–107 °C. 1H NMR (400 MHz, CDCl3) δ = 8.24 (d, J = 8.2 Hz, 1H),
104 °C. 1H NMR (400 MHz, CDCl3) δ = 8.22 (d, J = 8.1 Hz, 1H), 7.29– 7.19 (dd, J = 8.3, 1.8 Hz, 1H), 7.05 (s, 1H), 4.19 (d, J = 10.8 Hz, 1H),
7.25 (m, 1H), 7.14 (d, J = 6.1 Hz, 1H), 7.09 (td, J = 7.4, 1.1 Hz, 1H), 3.99 (d, J = 10.8 Hz, 1H), 2.63–2.53 (m, 4H), 2.46 (s, 3H), 1.36 (t, J =
4.10 (d, J = 10.9 Hz, 1H), 3.89 (dd, J = 10.9, 1.5 Hz, 1H), 2.58–2.40 7.4 Hz, 3H);13C NMR (101 MHz, CDCl3) δ = 171.88, 139.21, 138.05,
(m, 2H), 2.25 (s, 3H), 1.53 (d, J = 2.4 Hz, 3H); 13C NMR (101 MHz, 133.81, 129.45, 122.60, 117.17, 60.69 (d, J = 6.4 Hz), 41.81, 39.37 (t,
CDCl3) δ = 168.81, 141.28, 137.98, 128.98, 124.27, 122.10, 117.49, J = 20.3 Hz), 29.26, 26.59 (d, J = 3.6 Hz), 21.22, 8.84; 19 F NMR
61.50 (d, J = 6.2 Hz), 41.83, 39.41 (t, J = 20.6 Hz), 26.78 (d, J = 3.8 Hz), (376 MHz, CDCl 3 ) δ = –80.90 (t, J = 11.5 Hz, 3F), –107.95 to
24.38. 19F NMR (376 MHz, CDCl3) δ = –81.01 (t, J = 12.3 Hz, 3F), –114.06(m, 2F), –124.39 to –124.49 (m, 2F), –125.56 to –125.77 (m,
–107.46 to –114.59 (m, 2F), –124.46 to –124.58 (m, 2F), –125.60 to 2F); HRMS (ESI): m/z [M + H]+ calcd. for C18H19F9NO: 436.1317, found
–125.83 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for C16H15F9NO: 436.1319.
408.1004, found 408.1007.
1-(5-Chloro-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-
1-(3,5-Dimethyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)indolin-1- indolin-1-yl)propan-1-one (3ga): Yield 60 % (136.8 mg), white
yl)ethanone (3ba): Yield 80 % (172.8 mg), white solid, m.p. 119– solid, m.p. 104–105 °C. 1H NMR (400 MHz, CDCl3) δ = 8.19 (d, J =
120 °C. 11H NMR (400 MHz, CDCl3) δ = 8.09 (d, J = 8.2 Hz, 1H), 7.07 8.7 Hz, 1H), 7.23 (dd, J = 8.7, 2.2 Hz, 1H), 7.09 (d, J = 2.3 Hz, 1H),
(dd, J = 8.4, 1.6 Hz, 1H), 6.93 (s, 1H), 4.07 (d, J = 10.8 Hz, 1H), 3.88 4.10 (d, J = 10.8 Hz, 1H), 3.89 (d, J = 10.9 Hz, 1H), 2.50–2.40 (m, 4H),
(dd, J = 10.9, 1.6 Hz, 1H), 2.52–2.40 (m, 2H), 2.34 (s, 3H), 2.23 (s, 3H), 1.51 (s, 3H), 1.24 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ =
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 4 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
172.18, 140.19, 139.62, 128.96, 128.92, 122.50, 118.43, 60.65 (d, J = 2.66–2.29 (m, 2H), 1.55(d, J = 2.0 Hz, 3H); 13C NMR (101 MHz, CDCl3)
6.5 Hz), 41.87, 39.25 (t, J = 20.4 Hz), 29.28, 26.73 (d, J = 3.6 Hz), 8.73. δ = 167.30, 140.77, 138.95, 138.02, 134.91, 130.83, 130.14, 128.56,
19
F NMR (376 MHz, CDCl3) δ = –81.01 (t, J = 12.0 Hz, 3F), –107.95 127.46, 125.21, 124.81, 122.47, 117.66, 62.58, 41.54, 38.84 (t, J =
to –114.06 (m, 2F), –124.39 to –124.53 (m, 2F), –125.57 to –125.77 20.6 Hz), 26.08; 19F NMR (376 MHz, CDCl3) δ = –80.04 (t, J = 10.5 Hz,
(m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for C17H16ClF9NO: 456.0771, 3F), –108.63 to –114.06 (m, 2F), –124.42 to –124.52 (m, 2F), –125.60
found 456.0776. to –125.80 (m, 2F). HRMS (ESI): m/z [M + H]+ calcd. for
C21H16ClF9NO: 504.0771, found 504.0776.
1-(5-Chloro-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-
indolin-1-yl)-2,2-dimethylpropan-1-one (3ha): Yield 86 % 5-Chloro-3-methyl-1-(methylsulfonyl)-3-(2,2,3,3,4,4,5,5,5-nona-
(207.7 mg), white solid, m.p. 100–101 °C. 1H NMR (400 MHz, CDCl3) fluoropentyl)indoline (3ma): Yield 65 % (150.2 mg), yellow oil. 1H
δ = 8.17 (d, J = 8.7 Hz, 1H), 7.22 (dd, J = 8.8, 2.2 Hz, 1H), 7.09 (d, NMR (400 MHz, CDCl3) δ = 7.36 (d, J = 8.6 Hz, 1H), 7.23 (dd, J = 8.6,
J = 2.2 Hz, 1H), 4.30 (d, J = 10.8 Hz, 1H), 4.07 (dd, J = 10.8, 1.6 Hz, 2.1 Hz, 1H), 7.14 (d, J = 2.1 Hz, 1H), 3.99 (dd, J = 10.7, 0.9 Hz, 1H),
1H), 2.50–2.31 (m, 2H), 1.52 (d, J = 2.6 Hz, 3H), 1.37 (s, 9H); 13C NMR 3.85 (dd, J = 10.6, 1.7 Hz, 1H), 2.93 (s, 3H), 2.58–2.39 (m, 2H), 1.54
(101 MHz, CDCl3) δ = 176.71, 141.74, 139.62, 129.22, 128.73, 122.12, (d, J = 2.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 139.49, 139.19,
120.02, 61.65 (d, J = 6.6 Hz) 42.53, 40.28, 38.14 (t, J = 20.6 Hz), 27.67, 129.33, 129.31, 123.63, 114.72, 62.43 (d, J = 5.9 Hz), 41.81, 38.75 (t,
24.80, 24.76. 19F NMR (376 MHz, CDCl3) δ = –81.02 (t, J = 11.2 Hz, J = 20.6 Hz), 35.19, 26.44 (d, J = 3.1 Hz); 19F NMR (376 MHz, CDCl3)
3F), –107.73 to –114.73 (m, 2F), –124.44 to –124.53 (m, 2F), –125.38 δ = –81.06 (t, J = 10.9 Hz, 3F), –108.08 to –113.61 (m, 2F), –124.38
to –126.08 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for to –124.44 (m, 2F), –125.62 to –125.79 (m, 2F). HRMS (ESI): m/z [M
C19H20ClF9NO: 484.1084, found 484.1087. + H]+ calcd. for C15H14ClF9NO2S: 478.0285, found 478.0288.
1-(5-Chloro-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)- 3-Methyl-1-(methylsulfonyl)-3-(2,2,3,3,4,4,5,5,5-nonafluoro-
indolin-1-yl)octan-1-one (3ia): Yield 66 % (173.4 mg), white solid, pentyl)-5-phenylindoline (3na): Yield 75 % (194.5 mg), white solid,
m.p. 92–93 °C. 1H NMR (400 MHz, CDCl3) δ = 8.19 (d, J = 8.7 Hz, m.p. 115–116 °C. 1H NMR (400 MHz, CDCl3) δ = 7.57–7.51 (m, 2H),
1H), 7.22 (dd, J = 8.6, 2.2 Hz, 1H), 7.09 (d, J = 2.2 Hz, 1H), 4.11 (d, 7.49 (d, J = 1.2 Hz, 2H), 7.44 (t, J = 7.6 Hz, 2H), 7.38–7.32 (m, 2H),
J = 10.8 Hz, 1H), 3.90 (d, J = 10.8 Hz, 1H), 2.57–2.27 (m, 4H), 1.76– 4.02 (dd, J = 10.6, 0.9 Hz, 1H), 3.89 (dd, J = 10.6, 1.7 Hz, 1H), 2.96
1.69 (m, 2H), 1.52 (d, J = 2.3 Hz, 3H), 1.42–1.25 (m, 8H), 0.92–0.85 (s, 3H), 2.66–2.44 (m, 2H), 1.59 (d, J = 2.2 Hz, 3H); 13C NMR (101 MHz,
(m, 3H); 13 C NMR (101 MHz, CDCl 3 ) δ = 171.66, 140.19, 139.68, CDCl3) δ = 140.43, 139.83, 138.41, 137.70, 129.05, 128.31, 127.54,
128.93, 122.47, 118.52, 60.80 (d, J = 6.4 Hz), 41.85, 39.22 (t, J = 127.04, 121.94, 113.87, 62.58 (d, J = 5.9 Hz), 41.85, 38.96, 35.08,
20.5 Hz), 36.03, 31.82, 29.41, 29.26, 26.65 (d, J = 3.7 Hz), 24.65, 22.76, 26.48 (d, J = 3.5 Hz); 19F NMR (376 MHz, CDCl3) δ = –81.02 (t, J =
14.19. 19F NMR (376 MHz, CDCl3) δ = –81.02 (t, J = 11.4 Hz, 3F), 11.7 Hz, 3F), –107.91 to –113.66 (m, 2F), –124.32 to –124.40 (m, 2F),
–107.96 to –114.07 (m, 2F), –124.33 to –124.56 (m, 2F), –125.57 to –125.57 to –125.74 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for
–125.79 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for C22H26ClF9NO: C21H19F9NO2S: 520.0987, found 520.0989.
526.1554, found 526.1557.
5-Chloro-1-(ethylsulfonyl)-3-methyl-3-(2,2,3,3,4,4,5,5,5-nona-
1-(5-Bromo-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)- fluoropentyl)indoline (3oa): Yield 76 % (186.6 mg), yellow oil. 1H
indolin-1-yl)octan-1-one (3ja): Yield 59 % (167.9 mg), white solid, NMR (400 MHz, CDCl3) δ = 7.33 (d, J = 8.6 Hz, 1H), 7.20 (dd, J = 8.5,
m.p. 96–97 °C. 1H NMR (400 MHz, CDCl3) δ = 8.14 (d, J = 8.7 Hz, 2.1 Hz, 1H), 7.12 (d, J = 2.1 Hz, 1H), 4.09–4.01 (m, 1H), 3.90 (dd, J =
1H), 7.37 (dd, J = 8.6, 2.0 Hz, 1H), 7.24 (d, J = 2.0 Hz, 1H), 4.10 (d, 10.6, 1.7 Hz, 1H), 3.14 (q, J = 7.4 Hz, 2H), 2.57–2.39 (m, 2H), 1.53 (d,
J = 10.8 Hz, 1H), 3.89 (d, J = 10.8 Hz, 1H), 2.57–2.30 (m, 4H), 1.73 (p, J = 2.2 Hz, 3H), 1.42 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3)
J = 7.4 Hz, 2H), 1.51 (s, 3H), 1.42–1.25 (m, 8H), 0.93–0.84 (m, 3H); δ = 139.49, 139.29, 129.14, 128.83, 123.51, 114.69, 62.41 (d, J =
13
C NMR (101 MHz, CDCl 3 ) δ = 171.71, 140.68, 140.06, 131.88, 6.1 Hz), 44.88, 41.90, 38.79 (t, J = 20.5 Hz), 26.40 (d, J = 3.5 Hz), 7.84;
19
125.37, 118.99, 116.33, 60.76 (d, J = 6.2 Hz), 41.84, 39.26 (t, J = F NMR (376 MHz, CDCl3) δ = –81.06 (t, J = 11.3 Hz, 3F), –107.97
20.5 Hz), 36.07, 31.83, 29.41, 29.26, 26.69 (d, J = 3.4 Hz), 24.64, 22.76, to –113.79 (m, 2F), –124.40 to –124.49 (m, 2F), –125.61 to –125.79
14.19; 19 F NMR (376 MHz, CDCl 3 ) δ = –80.86 to –81.17 (m, 3F), (m, 2F); HRMS (ESI): m/z [M + H] + calcd. for C 16 H 16 ClF 9 NO 2 S:
–107.93 to –114.06 (m, 2F), –124.37 to –124.47 (m, 2F), –125.56 to 492.0441, found 492.0446.
–125.77 (m, 2F);HRMS (ESI): m/z [M + H]+ calcd. for C22H26BrF9NO:
1-(Ethylsulfonyl)-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoro-
570.1049, found 570.1050.
pentyl)-5-phenylindoline (3pa): Yield 74 % (197.2 mg), white solid,
tert-Butyl-5-chloro-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoro- m.p. 109–110 °C. 1H NMR (400 MHz, CDCl3) δ = 7.57–7.50 (m, 2H),
pentyl)indoline-1-carboxylate (3ka): Yield 84 % (209.6 mg), white 7.50–7.40 (m, 4H), 7.35 (d, J = 7.2 Hz, 2H), 4.09 (d, J = 10.6 Hz, 1H),
solid, m.p. 77–78 °C. 1H NMR (400 MHz, CDCl3) δ = 7.80 (s, 1H), 7.18 3.95 (dd, J = 10.6, 1.7 Hz, 1H), 3.18 (q, J = 7.4 Hz, 2H), 2.65–2.44 (m,
(dd, J = 8.6, 2.2 Hz, 1H), 7.06 (d, J = 2.2 Hz, 1H), 4.01 (d, J = 11.7 Hz, 2H), 1.58 (d, J = 2.2 Hz, 3H), 1.45 (t, J = 7.4 Hz, 3H); 13 C NMR
1H), 3.84 (d, J = 11.9 Hz, 1H), 2.56–2.29 (m, 2H), 1.57 (s, 9H), 1.48 (d, (101 MHz, CDCl3) δ = 140.51, 140.10, 138.23, 137.24, 129.02, 128.15,
J = 2.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 152.30, 140.08, 127.45, 127.00, 121.85, 113.80, 62.56 (d, J = 6.1 Hz), 44.71, 41.92,
139.52, 128.71, 127.66, 122.79, 116.23, 81.61, 60.60 (d, J = 5.9 Hz), 39.00 (t, J = 20.5 Hz), 26.44 (d, J = 3.4 Hz), 7.89; 19F NMR (376 MHz,
41.08, 39.39 (t, J = 20.5 Hz), 28.50, 26.84 (d, J = 2.9 Hz); 19F NMR CDCl3) δ = –80.03 (t, J = 11.3 Hz, 3F), –107.80 to –113.84 (m, 2F),
(376 MHz, CDCl3) δ = –81.09 (t, J = 10.2 Hz, 3F), –107.99 to –114.18 –124.36 to –124.42 (m, 2F), –125.57 to –125.75 (m, 2F); HRMS (ESI):
(m, 2F), –124.46 to –124.55 (m, 2F), –125.70 to –125.83 (m, 2F); m/z [M + H]+ calcd. for C22H21F9NO2S: 534.1144, found 534.1147.
HRMS (ESI): m/z [M + H]+ calcd. for C19H20F9NO2: 500.1033, found
4,6-Dichloro-1-(ethylsulfonyl)-3-methyl-3-(2,2,3,3,4,4,5,5,5-
500.1037.
nonafluoropentyl)indoline (3qa): Yield 72 % (188.9 mg), colorless
(3-Chlorophenyl)(3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropent- oil. 1H NMR (400 MHz, CDCl3) δ = 7.35 (d, J = 1.8 Hz, 1H), 7.00 (d,
yl)indolin-1-yl)methanone (3la): Yield 62 % (160.1 mg), colorless J = 1.8 Hz, 1H), 4.17 (d, J = 10.8 Hz, 1H), 3.90 (d, J = 10.7 Hz, 1H),
oil. 1H NMR (400 MHz, CDCl3) δ = 8.14 (s, 1H), 7.54 (t, J = 1.4 Hz, 3.22–3.13 (m, 2H), 2.89–2.65 (m, 2H), 1.65 (d, J = 1.6 Hz, 3H), 1.43
1H), 7.50–7.47 (m, 1H), 7.41 (d, J = 5.0 Hz, 2H), 7.29–7.16 (m, 2H), (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 143.84, 135.81,
7.12 (d, J = 7.4 Hz, 1H), 4.12 (d, J = 11.4 Hz, 1H), 4.02–3.70 (m, 1H), 131.52, 130.82, 124.64, 112.48, 62.20 (dd, J = 4.9, 2.7 Hz), 45.37,
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 5 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
42.77, 36.56, 25.64 (d, J = 2.8 Hz), 7.79; 19F NMR (376 MHz, CDCl3) (376 MHz, CDCl3) δ = –80.97 to –81.06 (t, J = 11.3 Hz, 3F), –107.70
δ = –81.05 (t, J = 12.0 Hz, 3F), –109.29 to –113.66 (m, 2F), –124.51 to –114.42 (m, 2F), –124.47 to –124.56 (m, 2F), –125.64 to –125.84
to –124.62 (m, 2F), –125.67 to –125.80 (m, 2F); HRMS (ESI): m/z [M (m, 2F); HRMS (ESI): m/z [M + H + calcd. for C22H21F9NO2S: 534.1144,
+ H]+ calcd. for C16H15Cl2F9NO2S: 526.0051, found 526.0051. found 534.1147.
N,N,3-trimethyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-5-phen- 5-Chloro-3-methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-1-
ylindoline-1-sulfonamide (3ra): Yield 71 % (194.6 mg), yellow (o-tolylsulfonyl)indoline (3wa): Yield 51 % (283.3 mg), colorless
solid, m.p. 123–124 °C. 1H NMR (400 MHz, CDCl3) δ = 7.58–7.51 (m, oil. 1H NMR (400 MHz, CDCl3) δ = 7.96 (dd, J = 7.9, 1.5 Hz, 1H), 7.48
2H), 7.50–7.39 (m, 4H), 7.37–7.30 (m, 2H), 4.05 (d, J = 10.5 Hz, 1H), (td, J = 7.5, 1.4 Hz, 1H), 7.40 (d, J = 8.6 Hz, 1H), 7.33 (t, J = 7.8 Hz,
3.88 (dd, J = 10.5, 1.8 Hz, 1H), 2.94 (s, 6H), 2.63–2.43 (m, 2H), 1.58 2H), 7.18 (dd, J = 8.6, 2.1 Hz, 1H), 7.07 (d, J = 2.1 Hz, 1H), 3.97 (dd,
(d, J = 2.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ = 140.98, 140.68, J = 10.9, 0.9 Hz, 1H), 3.80 (dd, J = 11.0, 1.7 Hz, 1H), 2.60 (s, 3H),
138.07, 136.86, 129.00, 128.00, 127.34, 127.01, 121.47, 114.35, 62.81 2.42–2.24 (m, 2H), 1.37 (d, J = 2.4 Hz, 3H); 13C NMR (101 MHz, CDCl3)
(d, J = 6.4 Hz), 41.92, 39.20, 39.00, 38.80, 38.39, 26.15 (d, J = 3.4 Hz); δ = 139.81, 139.71, 138.25, 136.90, 133.62, 133.20, 129.65, 129.07,
19
F NMR (376 MHz, CDCl3) δ = –80.90 to –81.00 (m, J = 10.9 Hz, 3F), 129.01, 126.60, 123.33, 115.98, 61.71 (d, J = 6.4 Hz), 41.98, 38.78 (t,
–107.78 to –114.40 (m, 2F), –124.40 to –124.50 (m, 2F), –125.57 to J = 20.5 Hz), 25.92 (d, J = 3.7 Hz), 20.89; 19F NMR (376 MHz, CDCl3)
–125.78 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for C22H22F9N2O2S: δ = –81.04 (t, J = 11.6 Hz, 3F), –107.82 to –114.23 (m, 2F), –124.42
549.1253, found 549.1253. to –124.48 (m, 2F), –125.63 to –125.82 (m, 2F); HRMS (ESI): m/z [M
+ H]+ calcd. for C21H18ClF9NO2S: 554.0598, found 554.0599.
3-Methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-1-(phenylsulf-
onyl)indoline (3sa): Yield 74 % (186.8 mg), yellow oil. 1 H NMR 4-Methyl-4-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-2-(o-tolylsulf-
(400 MHz, CDCl3) δ = 7.90–7.79 (m, 2H), 7.71 (d, J = 8.1 Hz, 1H), onyl)-1,2,3,4-tetrahydroisoquinoline (3xa): Yield 25 % (66.7 mg),
7.56 (t, J = 7.4 Hz, 1H), 7.46 (dd, J = 8.5, 7.0 Hz, 2H), 7.29–7.24 (m, colorless oil. 1H NMR (400 MHz, CDCl3) δ = 7.99 (dd, J = 7.9, 1.4 Hz,
1H), 7.10–6.99 (m, 2H), 3.99–3.90 (m, 1H), 3.80 (dd, J = 11.1, 1.6 Hz, 1H), 7.48 (td, J = 7.5, 1.4 Hz, 1H), 7.37 (d, J = 7.8 Hz, 1H), 7.32 (dd,
1H), 2.41–2.07 (m, 2H), 1.26 (d, J = 2.5 Hz, 3H); 13C NMR (101 MHz, J = 8.0, 3.8 Hz, 2H), 7.27–7.18 (m, 2H), 7.07– 7.05 (m, 1H), 4.52 (d,
CDCl3) δ = 140.31, 138.19, 136.99, 133.55, 129.29, 129.09, 127.30, J = 15.1 Hz, 1H), 4.31 (d, J = 15.1 Hz, 1H), 3.67 (d, J = 12.5 Hz, 1H),
124.25, 122.96, 114.97, 61.84 (d, J = 6.2 Hz), 41.75, 39.07, 26.21 (d, 3.10 (d, J = 12.5 Hz, 1H), 2.67 (s, 3H), 2.67–2.45 (m, 1H), 2.39–2.25
J = 3.6 Hz); 19F NMR (376 MHz, CDCl3) δ = –81.12 (t, J = 10.9 Hz, (m, 1H), 1.48 (d, J = 2.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ =
3F), –107.75 to –114.16 (m, 2F), –124.46 to –124.56 (m, 2F), –125.69 140.39, 138.32, 135.35, 133.36, 133.11, 130.84, 130.56, 127.62,
to –125.90 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for 127.23, 126.85, 126.49, 126.38, 53.72 (d, J = 4.3 Hz), 47.59, 38.08 (t,
C20H17F9NO2S: 506.0831, found 506.0836. J = 20.0 Hz), 37.59, 25.33 (d, J = 4.4 Hz), 20.93; 19F NMR (376 MHz,
CDCl3) δ = –81.12 (t, J = 10.7 Hz, 3F), –107.72 to –114.42 (m, 2F),
3-Methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-1-tosylindoline
–124.04 to –124.24 (m, 2F), –125.65 to –125.83 (m, 2F); HRMS (ESI):
(3ta): Yield 79 % (205.1 mg), pale yellow oil. 1H NMR (400 MHz,
m/z [M + H]+ calcd. for C22H21F9NO2S: 534.1144, found 534.1144.
CDCl3) δ = 7.70 (t, J = 8.4 Hz, 3H), 7.26 (t, J = 8.9 Hz, 3H), 7.04 (q,
J = 3.8 Hz, 2H), 3.92 (d, J = 11.1 Hz, 1H), 3.78 (dd, J = 11.1, 1.5 Hz, 1-(5-Chloro-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)indolin-1-yl)-
1H), 2.46–2.02 (m, 5H), 1.28 (d, J = 2.4 Hz, 3H); 13C NMR (101 MHz, ethanone (3ya): Yield 48 % (102.6 mg), white solid, m.p. 83–84 °C.
1
CDCl3) δ = 144.55, 140.46, 138.19, 134.01, 129.89, 129.05, 127.36, H NMR (400 MHz, CDCl3) δ = 8.17 (d, J = 8.7 Hz, 1H), 7.23 (dd, J =
124.13, 122.94, 115.01, 61.85 (d, J = 6.1 Hz), 41.73, 39.09, 26.14 (d, 8.7, 2.1 Hz, 1H), 7.17–7.10 (m, 1H), 4.41–4.28 (m, 1H), 3.97–3.79 (m,
J = 3.3 Hz), 21.55; 19F NMR (376 MHz, CDCl3) δ = –81.12 (t, J = 2H), 2.61 (dt, J = 30.9, 12.7 Hz, 1H), 2.45–2.30 (m, 1H), 2.24 (s, 3H);
13
11.3 Hz, 3F), –107.78 to –114.19 (m, 2F), –124.48 to –124.57 (m, 2F), C NMR (101 MHz, CDCl 3 ) δ = 168.68, 141.33, 133.77, 129.04,
–125.15 to –125.91 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for 123.85, 118.33, 55.41 (d, J = 4.4 Hz) 36.05 (t, J = 21.0 Hz), 34.10–
C21H19F9NO2S: 520.0987, found 520.0988. 32.85 (m), 24.22; 19 F NMR (376 MHz, CDCl 3 ) δ = –80.96 (t, J =
11.3 Hz, 3F), –111.86 to –114.15 (m, 2F), –124.22 to –124.33 (m, 2F),
3-Methyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-1-(o-tolylsulf-
–125.75 to –125.90 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for
onyl)indoline (3ua): Yield 32 % (83.2 mg), yellow oil. 1 H NMR
C15H12ClF9NO: 428.0458, found 428.0460.
(400 MHz, CDCl3) δ = 7.99 (d, J = 8.1 Hz, 1H), 7.52–7.39 (m, 2H),
7.32 (t, J = 8.1 Hz, 2H), 7.21 (t, J = 7.7 Hz, 1H), 7.11 (d, J = 7.5 Hz, 5-Chloro-1-(ethylsulfonyl)-3-(2,2,3,3,4,4,5,5,5-nonafluoropent-
1H), 7.04 (t, J = 7.4 Hz, 1H), 3.99 (d, J = 10.9 Hz, 1H), 3.82 (d, J = yl)indoline (3za): Yield 57 % (136.1 mg), yellow solid, m.p. 87–
11.6 Hz, 1H), 2.73–2.50 (m, 3H), 2.48–2.22 (m, 2H), 1.39 (d, J = 2.4 Hz, 88 °C. 1H NMR (400 MHz, CDCl3) δ = 7.33 (dd, J = 8.6, 1.5 Hz, 1H),
3H); 13C NMR (101 MHz, CDCl3) δ = 141.05, 138.26, 137.93, 137.32, 7.21 (dd, J = 8.6, 2.2 Hz, 1H), 7.17 (d, J = 2.0 Hz, 1H), 4.38–4.23 (m,
133.40, 133.11, 129.62, 128.96, 126.50, 123.88, 122.88, 114.89, 61.58 1H), 3.90–3.75 (m, 2H), 3.16–3.10 (m, 2H), 2.70–2.50 (m, 1H), 2.48–
(d, J = 6.3 Hz), 41.89, 38.94 (t, J = 20.6 Hz), 25.95 (d, J = 3.8 Hz) 2.27 (m, 1H), 1.46–1.34 (m, 3H); 13C NMR (101 MHz, CDCl3) δ =
20.87; 19F NMR (376 MHz, CDCl3) δ = –81.05 (t, J = 11.3 Hz, 3F), 140.74, 133.81, 129.25, 129.00, 124.79, 114.87, (d, J = 4.6 Hz), 45.53–
–107.76 to –114.36 (m, 2F), –124.45 to –124.52 (m, 2F), –125.64– 44.40 (m), 35.42 (t, J = 21.4 Hz), 33.59 (d, J = 3.2 Hz), 7.85; 19F NMR
125.84 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd. for C21H19F9NO2S: (376 MHz, CDCl3) δ = –81.06 (t, J = 11.3 Hz, 3F), –111.93 to –114.14
520.0987, found 520.0988. (m, 2F), –124.24 to –124.36 (m, 2F), –125.81 to –125.96 (m, 2F);
HRMS (ESI): m/z [M + H]+ calcd. for C15H14ClF9NO2S: 478.0285, found
3,5-Dimethyl-3-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-1-(o-tolyl-
478.0287.
sulfonyl)indoline (3va): Yield 39 % (104.0 mg), yellow oil. 1H NMR
(400 MHz, CDCl3) δ = 7.97 (dd, J = 8.2, 1.2 Hz, 1H), 7.50–7.42 (m, 1-(3-Methyl-3-(2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptyl)-
1H), 7.36–7.27 (m, 3H), 7.02–7.01 (m, 1H), 6.89 (d, J = 1.7 Hz, 1H), indolin-1-yl)ethanone (3ab): Yield 83 % (201.5 mg), white solid,
3.96 (dd, J = 11.0, 1.0 Hz, 1H), 3.80 (dd, J = 11.0, 1.7 Hz, 1H), 2.61 m.p. 126–127 °C. 1H NMR (400 MHz, CDCl3) δ = 8.22 (d, J = 8.1 Hz,
(s, 3H), 2.45–2.21 (m, 5H), 1.36 (d, J = 2.5 Hz, 3H); 13C NMR (101 MHz, 1H), 7.31–7.23 (m, 1H), 7.14 (s, 1H), 7.09 (dd, J = 7.4, 1.1 Hz, 1H),
CDCl3) δ = 138.66, 138.24, 138.19, 137.34, 133.71, 133.29, 133.07, 4.10 (d, J = 10.8 Hz, 1H), 3.94–3.85 (m, 1H), 2.57–2.40 (m, 2H), 2.25
129.62, 129.47, 126.45, 123.40, 114.80, 61.70 (d, J = 6.7 Hz), 41.92, (s, 3H), 1.53 (d, J = 2.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ =
38.95 (t, J = 20.4 Hz), 29.85, 25.84, 21.02 (d, J = 15.8 Hz); 19F NMR 168.79, 141.29, 138.00, 128.96, 124.26, 122.09, 117.49, 61.50 (d, J =
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 6 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
6.4 Hz), 41.85, 39.52 (t, J = 20.4 Hz), 26.75 (d, J = 3.7 Hz), 24.32; 19F 7.37–7.32 (m, 2H), 7.30–7.26 (m, 1H), 7.26–7.22 (m, 1H), 4.99 (d, J =
NMR (376 MHz, CDCl3) δ = –80.59 to –80.89 (t, J = 11.3 Hz, 3F), 14.6 Hz, 1H), 4.53 (d, J = 14.6 Hz, 1H), 3.51–3.37 (m, 2H), 2.43–2.07
–107.64 to –113.92 (m, 2F), –121.47 to –12163, (m, 2F), –122.73 to (m, 2H), 1.56 (d, J = 2.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ =
–122.86 (m, 2F), –123.53 to –123.64 (m, 2F), –126.01 to –126.18 (m, 164.36, 144.35, 138.80, 134.81, 132.83, 130.19, 129.43, 128.70,
2F); HRMS (ESI): m/z [M + H]+ calcd. for C18H15F13NO: 508.0941, 128.15, 128.06, 127.89, 126.83, 124.22, 55.68 (d, J = 3.9 Hz), 50.38,
found 508.0947. 36.91 (t, J = 20.3 Hz), 36.09, 22.86 (d, J = 2.0 Hz); 19F NMR (376 MHz,
CDCl3) δ = –81.06 (t, J = 11.9 Hz, 3F), –110.00 to –113.50 (m, 2F),
1-(3-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-Heptadecafluorononyl)-3-
–124.00 to –124.33 (m, 2F), –125.54 to –125.95 (m, 2F); HRMS (ESI):
methylindolin-1-yl)ethanone (3ac): Yield 50 % (151.8 mg), white
m/z [M + H]+ calcd. for C22H18ClF9NO: 518.0928; found: 518.0932.
solid. 1H NMR (400 MHz, CDCl3) δ = 8.22 (d, J = 8.1 Hz, 1H), 7.30–
7.24 (m, 1H), 7.13 (s, 1H), 7.09 (dd, J = 7.4, 1.1 Hz, 1H), 4.08 (s, 1H), (3,3,4,4,5,5,6,6,6-Nonafluorohex-1-ene-1,1-diyl)dibenzene (6):
3.94–3.85 (m, 1H), 2.61–2.38 (m, 2H), 2.25 (s, 3H), 1.53 (d, J = 2.4 Hz, Yield 45 % (89.7 mg), white solid, m.p. 71–72 °C. 1H NMR (400 MHz,
3H); 13C NMR (101 MHz, CDCl3) δ = 168.79, 141.29, 138.01, 128.97, CDCl3) δ = 7.43–7.30 (m, 6H), 7.25–7.21 (m, 4H), 6.09 (t, J = 14.7 Hz,
124.26, 122.09, 117.50, 61.51 (d, J = 6.3 Hz), 41.86, 39.53 (t, J = 3H); 13C NMR (101 MHz, CDCl3) δ = 154.59 (t, J = 4.5 Hz), 140.89,
20.4 Hz), 26.75 (d, J = 3.6 Hz), 24.33; 19F NMR (376 MHz, CDCl3) δ = 140.87, 137.62, 129.67, 129.16 (t, J = 2.8 Hz), 128.66, 128.49, 128.09,
–80.73(t, J = 11.3 Hz, 3F). –107.63 to –113.90 (m, 2F), –121.30 to 128.01, 112.79 (t, J = 21.1 Hz); 19F NMR (376 MHz, CDCl3) δ = –81.05
–121.86 (m, 2F), –122.30 to –123.56 (m, 6F), –123.54 (d, J = 15.0 Hz, (t, J = 10.9 Hz, 3F), –103.71 to –103.83 (m, 2F), –123.89 to –123.98
2F), –126.07 (dd, J = 20.1, 11.7 Hz, 2F). to –80.85 (m, 3F); HRMS (ESI): (m, 2F), –125.61 to –125.68 (m, 2F); HRMS (ESI): m/z [M + H]+ calcd.
m/z [M + H] + calcd. for C20H15F17NO: 608.0877, found 608.0879. for C18H12F9: 399.0790; found: 399.0794.
Ethyl 3-(1-acetyl-3-methylindolin-3-yl)-2,2-difluoropropanoate
(3ad): Yield 55 % (85.6 mg), yellow solid, m.p. 208–209 °C. 1H NMR Acknowledgments
(400 MHz, CDCl3) δ = 8.20 (d, J = 8.1 Hz, 1H), 7.26–7.21 (m, 1H),
7.11 (d, J = 1.4 Hz, 1H), 7.05 (td, J = 7.5, 1.1 Hz, 1H), 4.24–4.11 (m, This work was supported by the National Natural Science Foun-
3H), 3.82 (d, J = 10.7 Hz, 1H), 2.63–2.37 (m, 2H), 2.24 (s, 3H), 1.47 (d, dation of China (21702083), the Program for Innovative Re-
J = 1.6 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) search Team (in Science and Technology) in Universities of
δ = 164.36, 144.35, 138.80, 134.81, 132.83, 130.19, 129.43, 128.70, Yunnan Province, and the Yunnan Ten Thousand Talent Program
128.15, 128.06, 127.89, 126.83, 124.22, 55.68 (d, J = 3.9 Hz), 50.38, for Young Top-Notch Talents, and the key project of education
38.35–35.53 (m) 22.86; 13 C NMR (101 MHz, CDCl 3 ) δ = 168.83, department of Henan Province (Nos. 17A150050).
164.31, 163.99, 163.67, 141.65, 137.82, 128.75, 124.01, 122.40,
118.58, 117.37, 116.08, 113.57, 63.38, 61.45 (d, J = 4.5 Hz), 43.59 (t,
J = 22.0 Hz), 41.71, 27.08 (d, J = 2.6 Hz), 24.36, 13.96; 19F NMR Keywords: Copper · Fluoroalkylation · Homogeneous
(376 MHz, CDCl3) δ = –100.40 to –104.22 (m, 2F); HRMS (ESI): m/z catalysis · Nitrogen heterocycles · Radical reactions
[M + H]+ calcd. for C16H20F2NO3: 312.1406, found 312.1409.
(S)-2,4-Dimethyl-4-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-3,4-di- [1] a) P. Kirsh, Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applica-
hydroisoquinolin-1(2H)-one (5aa): Yield 57 % (85.6 mg), pale yel- tion, 2013; b) J. Nie, H. C. Guo, D. Cahard, J. A. Ma, Chem. Rev. 2011, 111,
low oil. 1H NMR (400 MHz, CDCl3) δ = 8.14 (dd, J = 7.8, 1.5 Hz, 1H), 455–529; c) I. Ojima, Fluorine in Medicinal Chemistry and Chemical Biology,
7.52 (td, J = 7.6, 1.6 Hz, 1H), 7.40 (td, J = 7.5, 1.2 Hz, 1H), 7.36–7.30 2009; d) K. Uneyama, K. Katagiri, H. Amii, Acc. Chem. Res. 2008, 41, 817–
(m, 1H), 3.58 (d, J = 13.0 Hz, 1H), 3.49 (d, J = 13.0 Hz, 1H), 3.18 (s, 829; e) J. A. Ma, D. Cahard, Chem. Rev. 2008, 108, PR1–PR43; f) S. Purser,
3H), 2.57–2.42 (m, 1H), 2.30–2.16 (m, 1H), 1.62 (d, J = 2.4 Hz, 3H); P. R. Moore, S. Swallow, V. Gouverneur, Chem. Soc. Rev. 2008, 37, 320–
13 330; g) M. Hird, Chem. Soc. Rev. 2007, 36, 2070–2095.
C NMR (101 MHz, CDCl 3 ) δ = 164.52, 144.76, 132.49, 129.07,
[2] For selected examples: a) B. Lantano, M. R. Torviso, S. M. Bonesi, S. Barata-
128.08, 127.91, 123.85, 57.52 (d, J = 4.2 Hz), 37.15, 36.95 (t, J =
Vallejo, A. Postigo, Coord. Chem. Rev. 2015, 285, 76–108; b) P. Chen, G.
20.4 Hz), 35.12, 22.73 (d, J = 5.0 Hz); 19F NMR (376 MHz, CDCl3) δ = Liu, Synthesis 2013, 45, 2919–2939; c) O. A. Tomashenko, V. V. Grushin,
–81.04 (t, J = 10.9 Hz, 3F), –110.61 to –113.28 (m, 2F), –124.29 to Chem. Rev. 2011, 111, 4475–4521; d) J. A. Ma, D. Cahard, Chem. Rev.
–124.40 (m, 2F), –125.69 to –125.82 (m, 2F); HRMS (ESI): m/z [M + 2004, 104, 6119–6146; e) T. Umemoto, Chem. Rev. 1996, 96, 1757–1778;
H]+ calcd. for C16H15F9NO: 408.1004; found: 408.1006. f) H. Egami, R. Shimizu, S. Kawamura, M. Sodeoka, Angew. Chem. Int. Ed.
2013, 52, 4000–4003; Angew. Chem. 2013, 125, 4092.
(S)-2-Benzyl-7-chloro-4-methyl-4-(2,2,3,3,4,4,5,5,5-nonafluoro- [3] For selected examples: a) X. Tang, A. Studer, Angew. Chem. Int. Ed. 2018,
pentyl)-3,4-dihydroisoquinolin-1(2H)-one (5ba): Yield 25 % 57, 814–817; Angew. Chem. 2018, 130, 822; b) R. Ren, Z. Wu, L. Huan, C.
(85.6 mg), white solid, m.p. 103–104 °C. 1H NMR (400 MHz, CDCl3) Zhu, Adv. Synth. Catal. 2017, 359, 3052–3056; c) N.-Y. Yang, Z.-L. Li, L. Ye,
δ = 8.18 (d, J = 2.4 Hz, 1H), 7.47 (dd, J = 8.3, 2.4 Hz, 1H), 7.38–7.23 B. Tan, X.-Y. Liu, Chem. Commun. 2016, 52, 9052–9055; d) Z.-L. Li, X.-H.
(m, 6H), 4.90 (d, J = 14.4 Hz, 1H), 4.65 (d, J = 14.4 Hz, 1H), 3.38 (q, Li, N. Wang, N.-Y. Yang, X.-Y. Liu, Angew. Chem. Int. Ed. 2016, 55, 15100–
J = 13.1 Hz, 2H), 2.35–2.09 (m, 2H), 1.51 (d, J = 1.9 Hz, 3H); 13C NMR 15104; Angew. Chem. 2016, 128, 15324; e) L. Li, Z.-L. Li, F.-L. Wang, Z.
(101 MHz, CDCl3) δ = 163.08, 142.24, 136.34, 134.25, 132.45, 129.79, Guo, Y.-F. Cheng, N. Wang, X.-W. Dong, C. Fang, J. Liu, C. Hou, B. Tan, X.-
Y. Liu, Nat. Commun. 2016, 7, 13852; f) Y. Li, A. Studer, Angew. Chem. Int.
129.26, 128.94, 128.76, 128.05, 126.14, 55.72 (d, J = 3.2 Hz), 50.76,
Ed. 2012, 51, 8221–8224; Angew. Chem. 2012, 124, 8345.
36.89 (t, J = 20.2 Hz), 35.76, 22.85 (t, J = 2.9 Hz); 19F NMR (376 MHz,
[4] For selected examples: a) Y. An, Y. Li, J. Wu, Org. Chem. Front. 2016, 3,
[D]Chloroform) δ = –81.13 (t, J = 10.5 Hz, 3F), –109.91 to –113.38 570–573; b) X.-J. Tang, W. R. Dolbier Jr., Angew. Chem. Int. Ed. 2015, 54,
(m, 2F), –124.27 to –124.37 (m, 2F), –125.69 – - 125.82 (m, 2F); HRMS 4246–4249; Angew. Chem. 2015, 127, 4320; c) S. Tang, Z.-H. Li, M.-W.
(ESI): m/z [M + H] + calcd. for C 22 H 18 ClF 9 NO: 518.0928; found: Wang, Z.-P. Li, R.-L. Sheng, Org. Biomol. Chem. 2015, 13, 5285–5288; d)
518.0931. W. Kong, M. Casimiro, N. Fuentes, E. Merino, C. Nevado, Angew. Chem.
Int. Ed. 2013, 52, 13086–13090; Angew. Chem. 2013, 125, 13324; e) X.
(S)-2-(3-Chlorobenzyl)-4-methyl-4-(2,2,3,3,4,4,5,5,5-nonafluoro- Mu, T. Wu, H.-y. Wang, Y.-l. Guo, G. Liu, J. Am. Chem. Soc. 2012, 134, 878–
pentyl)-3,4-dihydroisoquinolin-1(2H)-one (5ca): Yield 56 % 881.
(85.6 mg), white solid, m.p. 92–93 °C. 1H NMR (400 MHz, CDCl3) δ = [5] a) M. S. Kirillova, F. M. Miloserdov, A. M. Echavarren, Org. Chem. Front.
8.23–8.18 (m, 1H), 7.54 (td, J = 7.6, 1.6 Hz, 1H), 7.47–7.40 (m, 2H), 2018, 5, 273; b) M. Tercel, H. H. Lee, S. Y. Mehta, J. J. Youte Tendoung,
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 7 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
S. Y. Bai, H. D. S. Liyanage, F. B. Pruijn, J. Med. Chem. 2017, 60, 5834; c) J. 6892; e) H. Jiang, Y. He, Y. Cheng, S. Yu, Org. Lett. 2017, 19, 1240–1243;
Song, D. Chen, L. Gong, Natl. Sci. Rev. 2017, 4, 381; d) A. K. Singh, V. Raj, f) Q. Guo, M. Wang, Y. Wang, Z. Xu, R. Wang, Chem. Commun. 2017, 53,
S. Saha, Eur. J. Med. Chem. 2017, 142, 244; e) J. A. Homer, J. Sperry, J. 12317–12320; g) I. Behrends, S. Baehr, C. Czekelius, Chem. Eur. J. 2016,
Nat. Prod. 2017, 80, 2178; f) M. A. Corsello, J. Kim, N. Garg, Chem. Sci. 22, 17177–17181.
2017, 8, 5836; g) J. Yan, J. Chen, S. Zhang, J. Hu, L. Huang, X. Li, J. Med. [11] a) D. Liang, Y. Li, S. Gao, R. Li, X. Li, B. Wang, H. Yang, Green Chem. 2017,
Chem. 2016, 59, 5264; h) T. V. Sravanthi, S. L. Manju, Eur. J. Pharm. Sci. 19, 3344–3349; b) Y. Li, D. Liang, X. Li, W. Huang, L. Yuan, B. Wang, P.
2016, 91, 1; i) B. W. Megna, P. R. Carney, M. Nukaya, P. Geiger, G. D. Cheng, Heterocycl. Commun. 2017, 23, 29–34; c) D. Li, S. Li, C. Peng, L.
Kennedy, J. Surg. Res. 2016, 204, 47. Lu, S. Wang, P. Wang, Y.-H. Chen, H. Cong, A. Lei, Chem. Sci. 2019, 10,
[6] a) C. Zheng, S.-L. You, Chem 2016, 1, 830–857; b) X.-W. Liang, C. Zheng, 2791–2795; d) D.-D. Li, L.-F. Niu, Z.-Y. Ju, Z. Xu, C. Wu, Eur. J. Org. Chem.
S.-L. You, Chem. Eur. J. 2016, 22, 11918–11933; c) Q. Ding, X. Zhou, R. 2016, 2016, 3090–3096; e) D.-D. Li, Z.-Y. Li, G.-W. Wang, J. Org. Chem.
Fan, Org. Biomol. Chem. 2014, 12, 4807–4815. 2015, 80, 190–195; f) D.-D. Li, Y.-X. Cao, G.-W. Wang, Org. Biomol. Chem.
[7] a) L. Wang, S. Li, M. Blümel, R. Puttreddy, A. Peuronen, K. Rissanen, D. 2015, 13, 6958–6964; g) D.-D. Li, T.-T. Yuan, G.-W. Wang, J. Org. Chem.
Enders, Angew. Chem. Int. Ed. 2017, 56, 8516–8521; Angew. Chem. 2017, 2012, 77, 3341–3347; h) D.-D. Li, T.-T. Yuan, G.-W. Wang, Chem. Commun.
129, 8636; b) B.-L. Zhao, D.-M. Du, Chem. Commun. 2016, 52, 6162–6165; 2011, 47, 12789–12791.
c) S. Kayal, S. Mukherjee, Org. Biomol. Chem. 2016, 14, 10175–10179; d) [12] a) D. J. Burton, Z. Y. Yang, Tetrahedron 1992, 48, 189–275; b) D. Liang, Q.
D. Du, Y. Jiang, Q. Xu, X.-Y. Tang, M. Shi, ChemCatChem 2015, 7, 1366– Dong, P. Xu, Y. Dong, W. Li, Y. Ma, J. Org. Chem. 2018, Ahead of Print.
1371.
[13] For selected examples: a) Y.-L. Lai, D.-Z. Lin, J.-M. Huang, J. Org. Chem.
[8] J. Zheng, P. Chen, Y. Yuan, J. Cheng, J. Org. Chem. 2017, 82, 5790–5797.
2017, 82, 597–605; b) J.-J. Ma, W.-B. Yi, Org. Biomol. Chem. 2017, 15,
[9] D. Liang, Q. Dong, P. Xu, Y. Dong, W. Li, Y. Ma, J. Org. Chem. 2018, 83,
4295–4299; c) L. Chu, F.-L. Qing, J. Am. Chem. Soc. 2010, 132, 7262–7263;
11978–11986.
d) P. S. Fier, J. F. Hartwig, J. Am. Chem. Soc. 2012, 134, 5524–5527.
[10] For selected examples: a) D. Liang, D. Ge, Y. Lv, D. Liang, W. Huang, B.
[14] S. J. Barraza, S. E. Denmark, Synlett 2017, 28, 2891.
Wang, W. Li, J. Org. Chem. 2018, 83, 4681–4691; b) Y. Li, Y. Chang, Y. Li,
C. Cao, J. Yang, B. Wang, D. Liang, Adv. Synth. Catal. 2018, 360, 2488–
2492; c) X. Wang, S. Zhao, J. Liu, D. Zhu, M. Guo, X. Tang, G. Wang, Org.
Lett. 2017, 19, 4187–4190; d) X. Tang, A. Studer, Chem. Sci. 2017, 8, 6888– Received: May 9, 2019
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 8 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Full Paper
Fluroalkylation
D. Li,* Y. Wang, Z. Jia, Z. Ou,
Y. Dong, C. Lv, G. Fu, D. Liang* ...... 1–9
Cu-Mediated Synthesis of Indolines
and Dihydroisoquinolinones through The copper-mediated fluroalkylation/ moderate to good yields. This protocol
Arylperfluoroalkylation of Unacti- cyclization of N-allyl anilines has been combines a simple experimental pro-
vated Alkenes described with unactivated double cedure with low-costing fluoroalkyl-
bonds as the radical acceptor. The re- ated sources and excellent functional
action provides an efficient and direct group tolerance.
access to 3-fluoroalkyl indolines in
DOI: 10.1002/ejoc.201900680
Eur. J. Org. Chem. 0000, 0–0 www.eurjoc.org 9 © 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim